Inducible Pluripotent Stem Cells In Autism Spectrum Disorders

The Neuroscience of Autism Spectrum Disorders

Volumn , Issue , 2013, Pages 391-399

  Muotri, Alysson Renato ^a  

^a RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882678304     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-391924-3.00028-4     Document Type: Chapter

References (62)

1. Ananiev G., Williams E.C., Li H., Chang Q. Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model. PLoS One 2011, 6:e25255.
2. Baek K.H., Zaslavsky A., Lynch R.C., Britt C., Okada Y., Siarey R.J., et al. Down's syndrome suppression of tumor growth and the role of the calcineurin inhibitor DSCR1. Nature 2009, 459:1126-1130.
3. Bozdagi O., Sakurai T., Papapetrou D., Wang X., Dickstein D.L., Takahashi N., et al. Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Molecular Autism 2010, 1:15.
4. Bradley C.K., Scott H.A., Chami O., Peura T.T., Dumevska B., Schmidt U., et al. Derivation of Huntington's disease-affected human embryonic stem cell lines. Stem Cells and Development 2011, 20:495-502.
5. Brennand K.J., Simone A., Jou J., Gelboin-Burkhart C., Tran N., Sangar S., et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011, 473:221-225.
6. Bucan M., Abrahams B.S., Wang K., Glessner J.T., Herman E.I., Sonnenblick L.I., et al. Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genetics 2009, 5:e1000536.
7. Cheung A.Y., Horvath L.M., Grafodatskaya D., Pasceri P., Weksberg R., Hotta A., et al. Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Human Molecular Genetics 2012, 20:2103-2115.
8. Chin M.H., Mason M.J., Xie W., Volinia S., Singer M., Peterson C., et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009, 5:111-123.
9. Coufal N.G., Garcia-Perez J.L., Peng G.E., Yeo G.W., Mu Y., Lovci M.T., et al. L1 retrotransposition in human neural progenitor cells. Nature 2009, 460:1127-1131.
10. Dragunow M. The adult human brain in preclinical drug development. Nature Reviews Drug Discovery 2008, 7:659-666.
11. Ebert A.D., Yu J., Rose F.F., Mattis V.B., Lorson C.L., Thomson J.A., et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009, 457:277-280.
12. El-Fishawy P., State M.W. The genetics of autism: Key issues, recent findings, and clinical implications. Psychiatric Clinics of North America 2010, 33:83-105.
13. Geschwind D.H. Genetics of autism spectrum disorders. Trends in Cognitive Sciences 2011, 15:409-416.
14. Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J., Scherer S., et al. Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 2004, 428:493-521.
15. Gilman S.R., Iossifov I., Levy D., Ronemus M., Wigler M., Vitkup D. Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 2011, 70:898-907.
16. Giudice A., Trounson A. Genetic modification of human embryonic stem cells for derivation of target cells. Cell Stem Cell 2008, 2:422-433.
17. Grskovic M., Javaherian A., Strulovici B., Daley G.Q. Induced pluripotent stem cells - opportunities for disease modelling and drug discovery. Nature Reviews Drug Discovery 2011, 10:915-929.
18. Gutierrez R.C., Hung J., Zhang Y., Kertesz A.C., Espina F.J., Colicos M.A. Altered synchrony and connectivity in neuronal networks expressing an autism-related mutation of neuroligin 3. Neuroscience 2009, 162:208-221.
19. Ho R., Chronis C., Plath K. Mechanistic insights into reprogramming to induced pluripotency. Journal of Cellular Physiology 2011, 226:868-878.
20. Hu B.Y., Weick J.P., Yu J., Ma L.X., Zhang X.Q., Thomson J.A., et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:4335-4340.
21. Ji W., Foo J.N., O'Roak B.J., Zhao H., Larson M.G., Simon D.B., et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nature Genetics 2008, 40:592-599.
22. Kim K.Y., Hysolli E., Park I.H. Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:14,169-14,174.
23. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
24. Laurent L.C., Ulitsky I., Slavin I., Tran H., Schork A., Morey R., et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 2011, 8:106-118.
25. Levy D., Ronemus M., Yamrom B., Lee Y.H., Leotta A., Kendall J., et al. Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 2011, 70:886-897.
26. Lister R., Pelizzola M., Kida Y.S., Hawkins R.D., Nery J.R., Hon G., et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011, 471:68-73.
27. Liu G.H., Suzuki K., Qu J., Sancho-Martinez I., Yi F., Li M., et al. Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs. Cell Stem Cell 2011, 8:688-694.
28. Marchetto M.C., Brennand K.J., Boyer L.F., Gage F.H. Induced pluripotent stem cells (iPSCs) and neurological disease modeling: Progress and promises. Human Molecular Genetics 2011, 20:R109-R115.
29. Marchetto M.C., Carromeu C., Acab A., Yu D., Yeo G.W., Mu Y., et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010, 143:527-539.
30. Marchetto M.C., Winner B., Gage F.H. Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases. Human Molecular Genetics 2010, 19:R71-R76.
31. Marchetto M.C., Yeo G.W., Kainohana O., Marsala M., Gage F.H., Muotri A.R. Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS ONE 2009, 4:e7076.
32. Mateizel I., De Temmerman N., Ullmann U., Cauffman G., Sermon K., Van de Velde H., et al. Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Human Reproduction 2006, 21:503-511.
33. Mayshar Y., Ben-David U., Lavon N., Biancotti J.C., Yakir B., Clark A.T., et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010, 7:521-531.
34. Muotri A.R. Modeling epilepsy with pluripotent human cells. Epilepsy Behavior 2009, 14:81-85.
35. Muotri A.R., Chu V.T., Marchetto M.C., Deng W., Moran J.V., Gage F.H. Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature 2005, 435:903-910.
36. Muotri A.R., Gage F.H. Generation of neuronal variability and complexity. Nature 2006, 441:1087-1093.
37. Muotri A.R., Nakashima K., Toni N., Sandler V.M., Gage F.H. Development of functional human embryonic stem cell-derived neurons in mouse brain. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:18,644-18,648.
38. Muotri A.R., Marchetto M.C., Coufal N.G., Oefner R., Yeo G., Nakashima K., Gage F.H. L1 retrotransposition in neurons is modulated by MeCP2. Nature 2010, 468:443-446.
39. Pang Z.P., Yang N., Vierbuchen T., Ostermeier A., Fuentes D.R., Yang T.Q., et al. Induction of human neuronal cells by defined transcription factors. Nature 2011, 476:220-223.
40. Pasca S.P., Portmann T., Voineagu I., Yazawa M., Shcheglovitov A., Pasca A.M., et al. Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nature Medicine 2011, 17:1657-1662.
41. Pickering S.J., Minger S.L., Patel M., Taylor H., Black C., Burns C.J., et al. Generation of a human embryonic stem cell line encoding the cystic fibrosis mutation deltaF508, using preimplantation genetic diagnosis. Reproductive Biomedicine Online 2005, 10:390-397.
42. Robinton D.A., Daley G.Q. The promise of induced pluripotent stem cells in research and therapy. Nature 2012, 481:295-305.
43. Sanders S.J., Ercan-Sencicek A.G., Hus V., Luo R., Murtha M.T., Moreno-De-Luca D., et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 2011, 70:863-885.
44. Saporta M.A., Grskovic M., Dimos J.T. Induced pluripotent stem cells in the study of neurological diseases. Stem Cell Research and Therapy 2011, 2:37.
45. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., et al. Secreted amyloid beta-protein similar to that in the senile plaques of alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Medicine 1996, 2:864-870.
46. Silverman J.L., Yang M., Lord C., Crawley J.N. Behavioral phenotyping assays for mouse models of autism. Nature Reviews Neuroscience 2010, 11:490-502.
47. Soldner F., Laganiere J., Cheng A.W., Hockemeyer D., Gao Q., Alagappan R., et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 2011, 146:318-331.
48. Splawski I., Timothy K.W., Sharpe L.M., Decher N., Kumar P., Bloise R., et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004, 119:19-31.
49. Splawski I., Yoo D.S., Stotz S.C., Cherry A., Clapham D.E., Keating M.T. CACNA1H mutations in autism spectrum disorders. Journal of Biological Chemistry 2006, 281:22,085-22,091.
50. State M.W., Levitt P. The conundrums of understanding genetic risks for autism spectrum disorders. Nature Neuroscience 2011.
51. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
52. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
53. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
54. Tropea D., Giacometti E., Wilson N.R., Beard C., McCurry C., Fu D.D., et al. Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:2029-2034.
55. Urbach A., Bar-Nur O., Daley G.Q., Benvenisty N. Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 2010, 6:407-411.
56. Urbach A., Schuldiner M., Benvenisty N. Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells. Stem Cells 2004, 22:635-641.
57. Verlinsky Y., Strelchenko N., Kukharenko V., Rechitsky S., Verlinsky O., Galat V., et al. Human embryonic stem cell lines with genetic disorders. Reproductive Biomedicine Online 2005, 10:105-110.
58. Vierbuchen T., Wernig M. Direct lineage conversions: Unnatural but useful?. Nature Biotechnology 2011, 29:892-907.
59. Vierbuchen, T., Ostermeier, A., Pang, Z.P., Kokubu, Y., Sudhof, T.C., Wernig, M., 2010 Direct conversion of fibroblasts to functional neurons by defined factors. Nature.
60. Waterston R.H., Lindblad-Toh K., Birney E., Rogers J., Abril J.F., Agarwal P., et al. Initial sequencing and comparative analysis of the mouse genome. Nature 2002, 420:520-562.
61. Weiss L.A., Shen Y., Korn J.M., Arking D.E., Miller D.T., Fossdal R., et al. Association between microdeletion and microduplication at 16p11.2 and autism. New England Journal of Medicine 2008, 358:667-675.
62. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.